Trending | CAPR Plummets 15% on Thursday, Some Put options Increases 27%
On December 4, Eastern Time, Capricor Therap options saw a total of 136986 contracts traded, with calls accounting for 36% and puts making up 63%.
On December 4, Eastern Time, Capricor Therap options saw a total of 136986 contracts traded, with calls accounting for 36% and puts making up 63%.
Capricor Therap has 365683 contracts outstanding, with calls accounting for 35% and puts making up 64%.
The top volume gainer was the 2.5 dollars Put option expiring on December 19, 2025, with 14883 contracts traded.
On the news front, Based on recent key news:
1. Dec 5, Capricor Therapeutics announced a proposed underwritten public offering of its common stock, which led to a significant drop in share price. The company plans to use the proceeds for development and manufacturing of its product candidates. Shares fell 5.9% after hours. Source: Press Release
2. Dec 3, Capricor Therapeutics' shares surged 371% to an 8-year high after the company reported that its experimental cell therapy, deramiocel, slowed the progression of Duchenne muscular dystrophy in a late-stage trial. However, shares closed down 15.2% at $25.40 on Thursday. Source: Reuters
3. Dec 4, Analysts from multiple firms reiterated Buy ratings on Capricor Therapeutics, with price targets ranging from $41 to $60. Despite the positive outlook, the stock experienced volatility. Source: TipRanksBiotech sector remains volatile amid clinical trial results and stock offerings.
Please note: The chart below does not include options expiring within five days.
